Introduction
Platelets are primarily known for their crucial role in haemostatic processes but they do have far more functions. They play a role in inflammation by quickly reacting to various specific signals and releasing inflammatory mediators [1] . They modulate vascular reactions, release mediators for chemotaxis and stimulation of leukocytes, and participate in wound repair by release of PDGF, Angiopoietin or EGF [1] . In this way, platelets chip into all stages of inflammation.
Inflammation is often the consequence of invading pathogens, and it seems to be logical that platelets participate in antimicrobial host defense as they are the first cellular elements in the blood that accumulate at any site of a vascular lesion [2] [3] [4] . Various bacteria bind to platelets [5] [6] [7] and are embedded and killed in platelet aggregates [8;9] . The binding of bacteria can be a direct one via receptors or can be indirect via a bridging molecule like fibrinogen [10] .
Although a bactericidal function of platelets has been described for more than 120 years now, the underlying mechanisms are not clear [11] . Analogous to neutrophils, there are 3 potential killing mechanisms that may be proposed to operate in platelets: 1. platelets store and process bactericidal peptides, 2. they have a phagocytic capacity, and 3. they synthesize reactive oxygen species (ROS). As summarized below, mechanisms 1 and 2 have been under intensive investigation for longer times, but the possible role of ROS in killing bacteria by platelets has not been studied so far and stimulated the present study.
In 1972 Nachman and Weksler detected bactericidal peptides in platelet granules [4] . They were identified and described in detail in rabbits by Yeaman et al. [12] and later on in humans by Krijgsveld et al. [13] and Tang et al. [14] . But Tang et al. reported about conflicting data on bactericidal activities of purified peptides, possibly due to inhibitory effects of sodium phosphate [14] , which is also used in our experiments. Moreover, Krijgsveld et al. [13] needed 100-fold higher platelet concentrations to extract thrombocidins in bactericidal amounts than we used in our killing model. Therefore we asked if additional mechanisms exist that are responsible for the observed strong killing effects and one of them could be phagocytosis.
Platelets show three main phagocytic features that are typical for leucocytes [4;15] : they interact with particulate material, they contain lysosomes in the cytoplasm and they store inflammatory mediators. But true phagocytosis of bacteria, which means that the vacuoles have no permanent contact to the extracellular space, is not established in platelets yet.
Platelets enclose bacteria trapped within an aggregate or act as "covercytes" by covering the bacterial surface [16] . They also may take up bacteria into the open canalicular system [3;16] . White [16] concluded that bacteria-platelet interaction occurs spontaneously after prolonged incubation times or prestimulation of platelets. Since enclosing by platelets does not seem to alter bacteria morphologically, it is questionable if this mechanism of ingestion is bactericidal.
And finally, platelets could have the possibility to kill bacteria by synthesis of ROS [17] [18] [19] [20] [21] [22] [23] [24] , which act as potent killing agents with particularly high efficacy in leukocytes [25] . In this way, neutrophils and macrophages increase oxygen consumption during phagocytosis in what has been termed respiratory burst [26] . It was observed that ROS production in neutrophils and osteoclasts may be locally restricted to areas of "ruffled membranes" [27;28] . Since we found these ruffled membranes also in platelets, especially at platelet-bacteria binding sites [9] , we assumed that platelets could kill bacteria by the local release of ROS. Keeping in mind the analogies to neutrophils, we always investigated the ROS release by platelets and neutrophils simultaneously, taking the latter "big brothers" as the positive control.
Thus, we asked if ROS production in platelets is high enough to kill bacteria in general and if not so, if locally restricted ROS release might explain the observed killing effects. Since the amount of ROS released by platelets was not sufficient alone to explain the bactericidal effects, we further investigated the role of plasma proteins and the effect of thrombin in the observed killing model.
We tested the killing potential of gel-filtered platelets (plasma-free) in buffer and determined the killing rates after adding increasing plasma portions, furthermore after addition of heatinactivated plasma and after the addition of high (> 100 kDa) and low (<100 kDa) molecular weight plasma protein fractions.
Thrombin performs its platelet stimulation in humans via the protease activating receptors (PAR) 1 and 4 on the platelet surface [29;30] but also cleaves plasma proteins to generate fibrin [31] .
Because the addition of thrombin was crucial to get bactericidal effects, we dissected the action of thrombin by selecting the stimulation of the protease activating receptors (PAR) 1 and 4 on the platelet surface. We activated PAR 1 with the synthetic thrombin receptor agonist SFLLRN [32] and the PAR 4 with GYPGKF [33] , and determined the killing rates.
Furthermore, we mimicked the proteolytical function of thrombin by the addition of trypsin, we inhibited thrombin activity by hirudin, and compared all killing rates. 
Materials and Methods

Platelet and neutrophil preparation
Buffy coats (BC) or platelet concentrates (PC) were collected from healthy donors after informed consent and were kindly provided by Dr. Peter Schlenke from the Department of
Immunology and Blood Transfusion, University of Luebeck.
For photometric assays and fluorescence microscopy, BC were prepared by centrifugation (Optipac PL-146/Optipress, Baxter). Platelet-rich plasma was isolated by centrifugation of BC for 15 min at 160 x g and was allowed to rest for 20 min to recover from the trauma of centrifugation and compaction. PC were then obtained by centrifugation of platelet-rich plasma for 10 min at 1000 x g. Platelets were resuspended in Tyrode buffer, containing 138 mM NaCl, 2.7 mM KCl, 12 mM NaHCO 3 , 5 mM HEPES, 0.4 mM Na 2 HPO 4 , 1 mM MgCl 2 and 5 mM glucose [19] . The number of contaminating leukocytes was < 0.1 %.
Neutrophils were separated from other cells in the BC using a Histopaque1077 ® gradient centrifugation (Sigma, Schnelldorf, Germany) for 30 min at 400 x g followed by a subsequent ammonium chloride haemolysis [34] . Neutrophils were resuspended in RPMI 1640 ® medium (Sigma) and were counted in a Neubauer chamber.
For Killing assays, PC were prepared by plateletpheresis (Amicus ® cell separator, Baxter).
Platelet counts were adjusted to 6x10 8 /ml. PC were stored for a maximum of 3 days at 22°C
under constant agitation for better gas exchange and prevention of clumping.
Gel-filtered platelets were obtained by spinning down PC for 12 min at 1200 x g onto a 50 % albumin cushion [35] . Platelets were collected and resuspended in HEPES buffer containing 0.35 % BSA, 137 mM NaCl, 2.7 mM KCl, 3 mM Na 2 HPO 4 , 1 mM MgCl 2 , 5.5 mM glucose and 3.5 mM HEPES and then applied to a Sepharose 2B column (Sigma).
Bacteria suspensions
Bacillus subtilis (B. subtilis), Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus)
were grown on tryptone-soya agar plates (Oxoid, Wesel, Germany) at 37°C for 16 h. For killing experiments, bacteria were collected and suspended in 0.9 % sodium chloride to10 9 bacteria/ml.
Plasma preparation and fractionation
Human plasma was obtained by centrifugation of PC for 90 sec at 14 000 x g. To prepare
heat-inactivated plasma, the obtained plasma were incubated for 20 min at 56°C. (Millipore) YM-10 for 30 min at 14 000 g x and YM-100 for 12 min at 14 000 x g. We got 4 plasma protein fractions: < 10 kDa, > 10 kDa, < 100 kDa and > 100 kDa.
Serum preparation
Whole blood without any anticoagulants was allowed to clot until retraction of the fibrin clot.
After 30 min at 20 °C, the samples were centrifuged for 10 min at 3000 x g and the supernatant was collected.
Platelet stimulation and inhibition
To achieve maximum killing rates, platelets were stimulated with thrombin (Sigma) at a concentration of 2 U/ml for 10 min at 37°C. Inhibition of thrombin was performed by hirudin (Sigma) at a concentration of 5 antithrombin units/ml.
To stimulate the NAD(P)H-oxidase, we used phorbol myristate acetate (PMA, Sigma) at concentrations up to 1 µM. To block the NAD(P)H-oxidase, we used the unspecific NAD(P)H-oxidase inhibitor Diphenylene iodonium chloride (DPI; Sigma, 50-500 nM). Cells were preincubated with DPI for 30 min before any stimulation, and DPI was also present in the incubation medium.
For selective stimulation of the thrombin receptors, we stimulated PAR 1 with SFLLRN (SF, Sigma, 75 µM) and PAR 4 with GYPGKF (GYP, Sigma, 750 µM). To mimic a proteolytical action of thrombin, we used trypsin (Sigma, 64 000 U/ml).
Superoxide assay
The superoxide (O 2 -) production was measured by the reduction of cytochrom C as described by Krötz et al. [19] . Platelets were stimulated with PMA and thrombin or inhibited by DPI.
After incubation times of 15 min (neutrophils) or 30 min (platelets) at 37°C, the absorbance of the supernatants was measured with the spectrometer (Spectronic 20 Genesis) at 550 nm. The O 2 -dependent part of cytochrome C reduction was calculated from the absorbance difference between samples with or without addition of superoxide dismutase (SOD, 380 U/ml). The tests were performed in triplicates. The data were translated into nanomole (nM) of O 2 -using the extinction coefficient of E 550nM = 29.5 mM -1 x cm -1 . subtilis. Cells were diluted in ringer lactate solution (Fresenius, Bad Homburg, Germany) with addition of 5 mM glucose according to Telek et al. [37] . Samples were fixed with 2.5 % glutaraldehyde for 2 h and were washed in 0.1 M cacodylate puffer, pH 7.2. Postfixation was performed with 1 % osmiumtetroxide (OsO 4 ). Samples were dehydrated in ethanol and embedded in araldite (Fluka, Buchs, Switzerland). Ultrathin sections were stained with uranyl acetate and lead citrate and were viewed with a Philips EM 400.
Hydrogen peroxide assay
Killing assays
For quantitative detection of dead bacteria, we used DNA double labelling with the fluorescence dye LIVE/DEAD ® BacLight ™ (Molecular Probes, Eugene, USA). The rate of Three images per well were recorded using the multitrack mode. Numbers of green and red pixels between intensities 50-255 were counted automatically. We calculated the killing rates by dividing the number of red pixels by the sum of red and green pixels. Double coloured pixels (colocalised) were excluded.
Statistics
All data are expressed as mean ± standard deviation (SD). Statistical significance (p<0.05) was determined by using the Wilcoxon rank sum test performed by JMP® software (SAS Institute) and was characterized at the figures by an asterisk (*). (Fig.2 ).
Topological fluorescence analysis of H 2 O 2 -production by platelets
Since the level of ROS in the supernatant is not able to reflect a possible local enrichment of ROS, we tried to identify ROS topologically by fluorescence microscopy. PMA-stimulated neutrophils showed very bright fluorescent dots, likely phagolysosomes (Fig. 3A) . If platelets were stimulated with PMA, we found a very weak fluorescence signal surrounding some aggregated platelets (Fig. 3B) (Fig. 4 A-D) .
In contrast to neutrophils, platelets never showed any ceriumperhydroxide crystals at the plasma membrane, regardless of any stimulation. Although a lot of viable and dead B. subtilis were enclosed in platelet aggregates or in platelets themselves, no electron dense material was detectable at binding sites of B. subtilis, suggesting that no H 2 O 2 was produced at these sites (Fig.4 E-H) .
Promoting platelet ROS-generation does not lead to higher killing rates
B. subtilis is highly susceptible to thrombin-stimulated platelets with killing rates to nearly 100 % within 10 min. We compared these killing rates with those achieved following PMAstimulation of platelets. PMA does not yield any significant killing effect within 10 min was significantly higher than the control but did not reach the killing efficacy of stimulation with thrombin (Fig. 5, p<0 .001, Wilcoxon, n=5).
Inhibition of O 2 -does influence killing rates partially
To determine if the killing is ROS dependent, we also inhibited the superoxide generating that would be needed for effective killing of this bacteria.
Killing rates are dependent on addition of plasma
Blood plasma contains many adhesive proteins, which could enhance the binding of bacteria to platelets and thereby change the rate of killing. To determine the role of plasma components in the bactericidal mechanism of platelets, we used gel-filtered platelets with addition of increasing plasma portions.
Thrombin-stimulated platelets in buffer killed only 22 ± 22 % of the added bacteria, which was significantly less than the maximum control in plasma (p<0.001, Wilcoxon, n=3). But 13 already a proportion of 20 % plasma completely regains the bactericidal effect (100 %). If the plasma was heat-inactivated, no killing was observed (8 ± 3 % versus baseline 11.1 ± 2.8 %).
Plasma but not Serum is bactericidal after addition of thrombin
Because plasma seemed to be crucial for yielding high killing rates of B. subtilis, we tested if plasma can kill these bacteria without the addition of platelets.
Plasma without platelets showed no significant killing (19 ± 4 %). The addition of thrombin to plasma resulted in a high killing rate of 84 ± 17 %, which was still significantly below the maximum control shown in fig.5 (p=0.0011, Wilcoxon). The inhibition of thrombin activity by hirudin completely aborted bactericidal effects, also the incubation of B. subtilis with thrombin alone, without addition of plasma, did not show any significant killing (17 ± 8 %).
To exclude complement or antibody effects in the killing assay, we also tested the bactericidal effects of serum. But in the presence of serum there was no killing observed with (18 ± 7 %) or without the addition of thrombin (19 ± 6 %).
Plasma protein fraction > 100 kDa mediates the high killing rates
To determine the plasma component, which cause the high killing rates, we fractionated the plasma proteins with two filters in the MW ranges > 10 kDa, < 10 kDa, > 100 kDa and < 100 kDa and tested the killing rates after addition of these fractions to gel-filtered platelets.
It was determined, that the fraction > 100 kDa was responsible for a killing as high as 91 ± 8 %. The effects of the fractions > 100 kDa and > 10 kDa were not significantly different from killing rates in normal plasma (max-control), which reached 95 ± 5 % (p= 0.34, Wilcoxon). In contrast, the fractions < 100 kDa showed a decreased killing of 33 ± 8 % and the fraction < 10 kDa reached only 19 ± 8 % (Fig. 6 ).
Thrombin interaction with platelet receptors is not responsible for killing B. subtilis
In our experiments thrombin was always crucial for killing of B. subtilis. Therefore we studied which effect of thrombin was responsible for the observed killing. Thrombin activates human platelets via the protease activating receptors (PAR) 1 and 4. We dissected these effects by using the synthetic thrombin receptor agonists SFLLRN (SF) for activating the platelet PAR 1 and GYPGKF (GYP) for activating PAR 4. SF reached a maximum killing of 39 ± 19 %, whereas GYP achieved a maximum killing of 34 ± 20 %. Both activators together yielded a killing rate of 41 ± 20 %. To mimic the proteolytical function of thrombin, we also used trypsin in killing experiments. Trypsin reached a significant higher killing rate compared 
Discussion
While the critical role of platelets in haemostasis, thrombosis and inflammation is clearly identified, their contribution to the innate host defense has received much less attention though the bactericidal properties of blood and platelets have been described for the first time as early as one century ago [11] .
In analogy to leukocytes, 3 basic bactericidal mechanisms are thinkable to exist in platelets:
1. storage and processing of bactericidal proteins, 2. phagocytosis and 3. synthesis of reactive oxygen species (ROS).
Storage and processing of bactericidal proteins
In [13] . Surprisingly, these proteins differ from not bactericidal proteins by a proteolytical truncation of only 2 amino acids. The possibility exist, that thrombin or other extracellular proteases cleave a precursor protein, which contributes to the generation of bactericidal proteins [2] . According to these findings, Tang et al. [14] could identify more bactericidal proteins in human platelets, but two of them are only present in stimulated platelets.
In our model of killing of B. subtilis, however, several lines of evidence militate against a main role of bactericidal proteins. Platelet releasates, in our hands, only exert moderate killing effects [9] , and we observed a massive killing of bacteria with thrombin-stimulated platelets at about 100fold lower platelet concentrations in comparison to Krijgsveld et al. [13] .
Moreover, in earlier investigations we could show, that even completely degranulated platelets have bactericidal capacity [9] . A possible explanation for these conflicting data on bactericidal activity of platelet releasates is presented by Tang et al. [14] , who supposed an inhibiting effect of sodium phosphate which is used in most buffer systems. 
Phagocytosis
Lewis et al. [49] demonstrated for the first time that platelets really phagocytose small particles (<0.1 µm), which means that lysosomes fuse with the phagosome and no luminal continuity exists to the outer space. Latex particles were endocytosed through the OCS and reached the cytoplasm in small vesicles. But this way of ingestion is doubtful for bacteria with its much larger size (2 µm). Resuming the works of decades, Clawson found no evidences for a real phagocytosis of bacteria [3] . He observed that stimulated platelets recruit other platelets and the growing platelet aggregate surrounds initially adhered bacteria. There they are well separated from the surrounding media and usually appear within interspaces. But really engulfed bacteria are rarely to be seen in platelets [50] . Although granule secretion at plateletbacteria binding sites was observed, no killing of bacteria was described [3] . That is contrary to our investigations. Youssefian et al. [51] postulated an engulfment of Staphylococcus aureus in platelets, which is enhanced after stimulation. But he did not point out that killing occurs after engulfing. From White's updated point of view, bacteria are too big to be actively and completely enclosed within platelets. Therefore platelets may just cover bacteria as "covercytes" to separate this foreign material from the blood stream in vivo [16] .
Synthesis of reactive oxygen species
After phagocytosis by neutrophils, ROS play an important role in the definitive killing of pathogens. Several clues exist that also platelet-derived ROS could be engaged in host defense: ROS-dependent cytocidal effects were described in the platelet-mediated killing of helminths [52] , ruffled platelet membranes were observed at bacteria binding sites [9] , and a decreased killing of bacteria was observed to occur in the presence of antioxidants (own unpublished data). Thus we tried to establish the role of ROS in killing B. subtilis by platelets. First hints that platelet-derived ROS have cytocidal effects was given by Joseph et al. in IgEmediated killing of helminths [52;55] . This hypothesis is aided by our findings of ruffled membranes at platelet-bacteria binding sites which suggested similarities to ROS generating neutrophils [27] and osteoclasts [28] . In these cells, ruffled membranes are generated by actin Based on these reports and observations, we assumed a possible role for platelet-derived ROS in our bactericidal model. We focussed in our experiments on detecting the release of O 2 -and H 2 O 2 quantitatively as well as topologically, and we studied the influence of stimulation and inhibition of ROS-synthesis on the resulting killing rates.
B. subtilis is highly susceptible to the killing abilities of thrombin-stimulated platelets. It is a
Gram-and catalase-positive bacterium, which has 3 catalases [39] , and it should be well protected against the cytocidal effects of H 2 O 2 . In our experiments we detected that one platelet does produce about 1500 times less superoxide and 4000 times less The detection of very low levels of ROS with subsequent high standard deviations and the disappointing weak reaction to stimulators led us to the assumption, that aggregated platelets can not release all generated ROS into the supernatant. In this way, freshly synthesized ROS inside a platelet aggregate will be converted before it will be detected in the supernatant. That might explain the low ROS detection when strong aggregating agents like thrombin were used.
Another critical factor in the ROS assay is that the isolation process prestimulates platelets in a donor-dependent fashion, so that it is difficult to further increase ROS production with stimulators. Low amounts and prestimulated, aggregated platelets hamper the exact quantification of ROS release. Another delicate point is that platelet concentrates are not totally free of neutrophils. To assure about the cellular source of ROS (neutrophils or platelets), we used a direct local detection of ROS in addition to the cytochrom C or phenolred/peroxidase assays. Both electron and fluorescence microscopy revealed that no locally restricted ROS synthesis could be found at platelet-bacteria binding sites. In contrast Platelets might have found their own way, to participate in host defense.
Role of Thrombin and Plasma Proteins
In all experiments it was remarkable that the presence of plasma as well as a stimulation by thrombin was essential to kill B. subtilis. Gel-filtered and thrombin-stimulated platelets showed no killing effects until at least a portion of 20 % plasma was added. In contrast, heatinactivated plasma, a plasma protein fraction < 100 kDa, serum or thrombin alone offered no killing potential. Therefore complement or antibody action in that killing can be excluded, because these components are also present in the serum.
Furthermore, the action of thrombin was mimicked by the synthetic thrombin receptor agonists SFLLRN or GYPGKF, which stimulated the platelets without having any proteolytic effects [32;33] . Although the platelets were activated and degranulated, no remarkable killing of B. subtils occured.
In conclusion, the observed bactericidal effects do not seem to be mainly due to an active contribution of platelets, like bactericidal peptides, the production of ROS or phagocytosis.
The present work rather suggests that platelets contribute to the innate host defense by providing a catalytical surface for synthesis of thrombin. Thrombin was always added in our in-vitro experiments, but can be generated in vivo only in close contact to the platelet surface.
Inhibition of thrombin by hirudin completely abolishes all bactericidal activity of plasma in our experiments. In the presence of a heat-instable plasma protein with a MW > 100 kDa, the [57] .
In several clinical studies it was described, that thrombocytopenia in man is also accompanied by higher morbidity and mortality. An increased incidence and severity of lobar pneumonia in elderly individuals with thrombocytopenia was described [61] , thrombocytopenia was found to be a significant predictor of mortality in pneumococcal meningitis [62] , and in liver transplant recipients thrombocytopenia is an independent and significant predictor associated with increased infection and related morbidity and mortality [63] .
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F
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